continuous manufacturing of drug product (20of33) quality – oct. 16-17, 2019
Published 4 years ago • 3.8K plays • Length 26:11
Download video MP4
Download video MP3
Similar videos
-
18:17
case studies: continuous manufacturing of drug substance (21of33) quality – oct. 16-17, 2019
-
20:18
end-to-end integrated continuous manufacturing (25of33) quality – oct. 16-17, 2019
-
20:53
policy considerations for continuous manufacturing (19of33) quality – oct. 16-17, 2019
-
26:22
application manufacturing assessment (4of33) quality – oct. 16-17, 2019
-
20:20
quality considerations for continuous manufacturing of apis
-
25:06
quality assessment of blas, ndas, and andas (3of33) quality – oct. 16-17, 2019
-
14:31
biosimilars and interchangeables - regulatory highlights (27of33) quality – oct. 16-17, 2019
-
0:33
eli lilly glp-1 shortage officially over, hims & hers takes a hit #lly #hims #glp1
-
23:35
fda’s quality assessment and knowledge management - kasa (11of33) quality – oct. 16-17, 2019
-
22:17
pharmaceutical quality surveillance program (14of33) quality – oct. 16-17, 2019
-
24:28
change management: ich q12 and established conditions (12of33) quality – oct. 16-17, 2019
-
26:41
small molecule case studies (8of33) quality – oct. 16-17, 2019
-
24:48
fda perspectives on biosimilar bla-manufacturing (28of33) quality – oct. 16-17, 2019
-
20:49
assessment of the multi-attribute method (mam) substance (23of33) quality – oct. 16-17, 2019
-
18:30
emerging technology program (18of33) quality – oct. 16-17, 2019
-
16:24
fda research supporting emerging technologies with case studies (24of33) quality – oct. 16-17, 2019
-
15:58
quality considerations for transition biological products (32of33) quality – oct. 16-17, 2019
-
20:08
quality-related compliance actions and trends (15of33) quality – oct. 16-17, 2019
-
45:48
manufacturing process and controls: avoiding assessment issues (26of28) gdf – apr. 3-4, 2019
Clip.africa.com - Privacy-policy